C

CT Clinical Research | Cromwell, CT

Research site
(Unclaimed)
Location
160 West Street, Suite 1A, Cromwell, Connecticut, United States of America
Site insights

Top conditions

Migraine Disorders (5 trials)

Depression (3 trials)

Major Depressive Disorder (3 trials)

Depressive Disorder (3 trials)

Attention Deficit Disorder with Hyperactivity (1 trial)

Top treatments

JZP150
Cariprazine
Dasotraline
Pimavanserin
Zavegepant
BHV-3500
Quetiapine
Simufilam
BI 1358894

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 12
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of moderate or severe migraine in children and adolesc...

Enrolling
Acute Treatment of Migraine
Drug: Rimegepant / BHV3000

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling
Pediatric Migraine
Drug: Rimegepant/BHV3000
Drug: Matching placebo

A 52-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 52 we...

Active, not recruiting
Alzheimer Disease
Drug: Simufilam
Drug: Placebo

Trial sponsors

Pfizer logo

Pfizer (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems